Grant: Alliance Grants
Université Laval
$99,400.00
Innovative bioabsorbable zinc-based materials for potential application as cerebrovascular stents (Alliance International)
EF 2024-25
Résumé
The use of biodegradable metals, that is Mg-, Fe-, and Zn-based alloys, is becoming more and more popular in modern biomedical applications; the possibility to fine tuning their properties, from a mechanical, electrochemical and biological point of view, make them suitable for critical intravascular applications, such as their use as cardiovascular or neurovascular devices. In particular, Zn alloys properties can be improved modifying their chemical composition, microstructure, and surface characteristics. The present proposal describes the plan drawn by the Laboratory of Biomaterials and Bioengineering (LBB - ULaval, CA) to modify the surface properties of advanced Zn alloys designed at the Materials Science Institute (of the Polish Academy of Sciences, PL). The international partner scientific knowledge and technical skills on the design and development of thermomechanical processing (casting followed by hydrostatic extrusion), and the microstructural/textural characterization by advanced electron microscopy techniques, will be providential to target the final properties that clinics demand these alloys to show. After pre-treatment, surface modification processes through low pressure plasma will be applied in LBB, to modify the chemical composition, the morphology, the surface energy and the microstructure, in such a way that the degradation processes, and the biological properties can be finely tailored. The features of the modified materials will be characterized through LBB surface equipment (x-ray photoelectron spectroscopy, atomic force microscopy, etc.) and validated through hemocompatibility and indirect cell viability tests, on compatible cell lines (for example endothelial and smooth muscle cells) with the final application. The strategic relevance of this research field is underlined by the market growth of neurovascular stents, from 1,045 (2021) to 2,240 billion US$ (2029) with a 10.0% CAGR, and of biodegradable alloys, from 10 (2024) to 22.02 billion US$ (2031) with a 14.06% CAGR. The present project is thus laying the ground to increase the competitivity of Canada in the field of highly added-value biomedical materials, and devices for applications in Health.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
597772-2024
Name nom
Mantovani, Diego D
Department département
Génie des mines, métallurgie et matériaux
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
99400
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
2000
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Materials science and technology
Research subject fr
Science et technologie des matériaux
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Innovative bioabsorbable zinc-based materials for potential application as cerebrovascular stents (Alliance International)
Keywords
biodegradable metals; biological performances; bioresorbable metals; characterization; materials science and engineering; metallic alloys; microstructure; structure-property relationships; surface modifications; texture
Application summary
The use of biodegradable metals, that is Mg-, Fe-, and Zn-based alloys, is becoming more and more popular in modern biomedical applications; the possibility to fine tuning their properties, from a mechanical, electrochemical and biological point of view, make them suitable for critical intravascular applications, such as their use as cardiovascular or neurovascular devices. In particular, Zn alloys properties can be improved modifying their chemical composition, microstructure, and surface characteristics. The present proposal describes the plan drawn by the Laboratory of Biomaterials and Bioengineering (LBB - ULaval, CA) to modify the surface properties of advanced Zn alloys designed at the Materials Science Institute (of the Polish Academy of Sciences, PL). The international partner scientific knowledge and technical skills on the design and development of thermomechanical processing (casting followed by hydrostatic extrusion), and the microstructural/textural characterization by advanced electron microscopy techniques, will be providential to target the final properties that clinics demand these alloys to show. After pre-treatment, surface modification processes through low pressure plasma will be applied in LBB, to modify the chemical composition, the morphology, the surface energy and the microstructure, in such a way that the degradation processes, and the biological properties can be finely tailored. The features of the modified materials will be characterized through LBB surface equipment (x-ray photoelectron spectroscopy, atomic force microscopy, etc.) and validated through hemocompatibility and indirect cell viability tests, on compatible cell lines (for example endothelial and smooth muscle cells) with the final application. The strategic relevance of this research field is underlined by the market growth of neurovascular stents, from 1,045 (2021) to 2,240 billion US$ (2029) with a 10.0% CAGR, and of biodegradable alloys, from 10 (2024) to 22.02 billion US$ (2031) with a 14.06% CAGR. The present project is thus laying the ground to increase the competitivity of Canada in the field of highly added-value biomedical materials, and devices for applications in Health.